Results 121 to 130 of about 30,364 (243)

[Autoimmune hemolytic anemia].

open access: yesTidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2009
Knowledge of autoimmune hemolytic anemia is rapidly increasing, especially on pathogenesis, associated disorders and aspects of transfusion immunology. New treatment options have emerged.This review is based on selected publications, a non-systematic search in PubMed and the authors' own research.Autoimmune hemolytic anemia is a heterogeneous group of ...
Sigbjørn, Berentsen   +3 more
openaire   +1 more source

Clinical Features and Associated Factors of Lupus Myocarditis: A Case‐Control Study

open access: yesImmunity, Inflammation and Disease, Volume 14, Issue 4, April 2026.
ABSTRACT Objectives This study aimed to explore the clinical characteristics of patients with lupus myocarditis (LM) and to evaluate the efficacy of rituximab (RTX) in LM treatment. Methods The medical records of all patients with LM admitted to our hospital between January 2012 and March 2025 were retrospectively analyzed.
Dong Yan   +4 more
wiley   +1 more source

Paroxysmal Nocturnal Haemoglobinuria‐Associated Acute Cutaneous Thrombosis and Haemolysis in the Setting of Parvovirus B19 and Varicella Zoster Virus Infection

open access: yeseJHaem, Volume 7, Issue 2, April 2026.
ABSTRACT A 28‐year‐old male with paroxysmal nocturnal haemoglobinuria (PNH) presented with headache, nasal bridge discomfort and haemoglobinuria. He developed a macular‐papular rash which rapidly progressed into purpura, necrosis and peri‐orbital oedema. Investigations demonstrated severe haemolytic anaemia and acute parvovirus B19 infection.
Louise J. Potter   +9 more
wiley   +1 more source

Liver Cirrhosis and In‐Hospital Outcomes in Patients With Sickle Cell Crises

open access: yeseJHaem, Volume 7, Issue 2, April 2026.
ABSTRACT Introduction Sickle cell disease (SCD) is a hematologic disorder characterized by chronic hemolysis, vaso‐occlusion, and end‐organ dysfunction. Patients with SCD may experience acute episodes known as sickle cell crises, which are sudden, severe complications typically involving pain or organ‐specific manifestations resulting from vaso ...
Shakirat Gold‐Olufadi   +14 more
wiley   +1 more source

Autoimmune hemolytic anemia in children

open access: yesPediatric Hematology Oncology Journal
Autoimmune hemolytic anaemia (AIHA) is an uncommon cause of antibody-induced hemolytic anemia in children. It is divided into three categories: warm AIHA, cold antibody AIHA and paroxysmal cold hemoglobinuria. The diagnostic work-up typically begins with
Dinesh Chandra   +3 more
doaj   +1 more source

Management of autoimmune hemolytic anemia in children and adolescents: A single center experience [PDF]

open access: yes, 2011
Objective: To present and discuss the treatment of autoimmune hemolytic anemia (AIHA). Materials and Methods: The medical records of all patients (n=19) diagnosed in a tertiary hematology center between 1999 and 2010 were retrospectively reviewed.Results:
Emine Zengin   +3 more
core  

Silent Presentation, Significant Threat: Cold Agglutinin Syndrome After Haploidentical Hematopoietic Stem Cell Transplantation

open access: yeseJHaem, Volume 7, Issue 2, April 2026.
This graphic abstract presents a comprehensive overview of cold agglutinin syndrome (CAS) following haploidentical hematopoietic stem cell transplantation (haplo‐HSCT) based on the content of our letter, including its clinical scenarios, potential triggers, pathophysiological mechanisms, clinical manifestations, as well as therapeutic and management ...
Zhuoyu An   +18 more
wiley   +1 more source

Noonan Syndrome Presenting With Severe Transient Thrombocytopenia and Hemolytic Anemia in a Neonate With a Germline PTPN11 Pathogenic Variant

open access: yeseJHaem, Volume 7, Issue 2, April 2026.
ABSTRACT Noonan syndrome (NS) is a RASopathy that can have hematological presentations, most commonly NS‐related myeloproliferative disorder (NS/MPD) and juvenile myelomonocytic leukemia. Other neonatal hematologic presentations remain poorly defined.
Ariel Gershon   +4 more
wiley   +1 more source

Application and Challenges of Chimeric Antigen Receptor T Cell Therapy in Systemic Rheumatic Diseases and Autoimmune Disorders

open access: yesMedComm, Volume 7, Issue 4, April 2026.
CAR‐T cell therapy in systemic rheumatic diseases and autoimmune disorders. (This figure was created using BioRender.com.) ABSTRACT Chimeric antigen receptor T (CAR‐T) cell therapy, originally developed for hematologic malignancies, has emerged as a transformative candidate for systemic rheumatic diseases and autoimmune disorders (AIDs).
Zhidan Fan, Li Zhang, Haiguo Yu
wiley   +1 more source

Home - About - Disclaimer - Privacy